USP45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.020430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.953200E-01
Normal-vs-Stage2
6.390100E-02
Normal-vs-Stage3
2.504800E-01
Normal-vs-Stage4
5.256400E-01
Stage1-vs-Stage2
5.970400E-01
Stage1-vs-Stage3
2.039600E-01
Stage1-vs-Stage4
9.557400E-01
Stage2-vs-Stage3
1.864770E-01
Stage2-vs-Stage4
4.942000E-01
Stage3-vs-Stage4
1.228560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.159210E-01
Normal-vs-AfricanAmerican
5.106600E-01
Normal-vs-Asian
6.752200E-02
Caucasian-vs-AfricanAmerican
3.990400E-01
Caucasian-vs-Asian
1.763200E-01
AfricanAmerican-vs-Asian
9.521600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.041200E-01
Normal-vs-Female
1.253620E-01
Male-vs-Female
6.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.074600E-01
Normal-vs-Age(41-60Yrs)
2.110400E-01
Normal-vs-Age(61-80Yrs)
6.670300E-02
Normal-vs-Age(81-100Yrs)
3.534000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.354400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.778400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.853200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.598800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.755400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.707200E-01
Normal-vs-Daily Drinker
2.871800E-01
Normal-vs-Weekly Drinker
1.277980E-01
Normal-vs-Occasional Drinker
4.484200E-01
Normal-vs-Social Drinker
1.008620E-01
Non Drinker-vs-Daily Drinker
1.781030E-01
Non Drinker-vs-Weekly Drinker
5.832200E-01
Non Drinker-vs-Occasional Drinker
1.365960E-01
Non Drinker-vs-Social Drinker
7.690400E-01
Daily Drinker-vs-Weekly Drinker
1.019630E-01
Daily Drinker-vs-Occasional Drinker
2.414100E-02
Daily Drinker-vs-Social Drinker
1.581630E-01
Weekly Drinker-vs-Occasional Drinker
3.516400E-01
Weekly Drinker-vs-Social Drinker
8.232000E-01
Occasional Drinker-vs-Social Drinker
2.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.141000E-01
Normal-vs-Grade 2
1.830760E-01
Normal-vs-Grade 3
1.822440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.765430E-01
Grade 1-vs-Grade 3
2.268200E-01
Grade 1-vs-Grade 4
2.141000E-01
Grade 2-vs-Grade 3
9.040400E-01
Grade 2-vs-Grade 4
1.830760E-01
Grade 3-vs-Grade 4
1.822440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.321800E-02
Normal-vs-NonDiabetic
6.068500E-02
Diabetic-vs-NonDiabetic
2.221000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.905400E-01
Normal-vs-NoPancreatitis
6.086400E-02
Pancreatitis-vs-NoPancreatitis
1.323810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.715600E-01
Normal-vs-N1
4.210000E-01
N0-vs-N1
4.143000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.153200E-01
Normal-vs-TP53-NonMutant
5.044800E-01
TP53-Mutant-vs-TP53-NonMutant
1.003570E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
